Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

NIH 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 8Other solid neoplasm 4Dermatologic 4Genitourinary 3Gastrointestinal 3Head & Neck 2Gynecologic 2CNS 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Endocrine 1Classical hematology 1Breast 1

Conditions

Rectal Neoplasms 2Colonic Neoplasms 2Sarcoma 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Semaxinib × Gastrointestinal × Clear all
NCT00005862 2013-02-11

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
GastrointestinalSarcoma

Sarcoma, Gastrointestinal Stromal Tumors

NCT00005818 2013-01-23

SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer

National Cancer Institute (NCI)

Phase 1/2 Completed
68 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00004252 2012-09-11

Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Pfizer

Phase 3 Completed
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡